Epigral Limited
Bandhan Mutual Fund increased its stake in Epigral Limited from 2.31% to 2.95%, acquiring 2,76,478 additional shares. The transaction value is approximately ₹29.08 crore, calculated at a share price of ₹1051.90.
An integrated manufacturer of specialty chemicals, Epigral produces a diverse range of chemical products for industrial applications across multiple sectors including pharmaceuticals, agrochemicals, and specialty materials. The company operates integrated manufacturing facilities that enable vertical control over production processes and supply chains. Epigral serves customers globally with customized chemical solutions and maintains a commitment to sustainable manufacturing practices.
Formerly IDFC Mutual Fund, rebranded after Bandhan Financial Holdings acquired IDFC's AMC in 2023. Manages over Rs 1.5 lakh crore. Known for strong debt and liquid funds, plus well-regarded equity offerings including the IDFC-lineage Sterling Value Fund and Focused Equity Fund. One of the cleaner transitions in Indian AMC ownership history.